Table 1.
Patient No./Sex/ Age at Onset, y/Symptom Duration, y | Pertinent Medical History | Previous Ineffective Therapies | Therapies With at Least Partial Efficacy |
---|---|---|---|
1/F/38/9 | Depression, chronic pain, cervical stenosis, fibromyalgia, migraines, essential tremor, Raynaud phenomenon | Topical steroids, topical clindamycin | Gabapentin, combination cream of ketamine, 15%/amitriptyline, 5%/clonidine, 0.2%/ketoprofen, 10% |
2/F/45/15 | Depression, migraines | Topical capsaicin, pregabalin, tramadol | Gabapentin, duloxetine |
3/F/25/10 | Acne vulgaris, migraines, allergic contact dermatitis | Oral tetracyclines, topical metronidazole, nadolol, gabapentin, amitriptyline | Amoxicillin, desonide for itch |
4/F/50/10 | Carpal tunnel syndrome, autoimmune thyroiditis, chronic pain, neurogenic itch, spondylolisthesis | NA | Gabapentin, duloxetine |
5/F/36/8 | Complex regional pain syndrome, positive ANA without other known autoimmune disease | Oral antibiotics, topical steroids | Pregabalin, duloxetine |
6/F/29/8 | Mixed connective tissue disease, Raynaud phenomenon, depression, bulimia | Topical metronidazole, hydroxychloroquine | Gabapentin, minocycline |
7/M/37/13 | Scrotal dysesthesia, psoriasis, C3–6 degenerative joint disease | Topical metronidazole | Minocycline, doxycycline |
8/F/41/17 | Rheumatoid arthritis | Topical metronidazole, topical steroids, oral antibiotics, β-blockers, gabapentin, hydroxychloroquine, amitriptyline | Nortriptyline |
9/M/15/10 | Psoriatic arthritis, irritable bowel syndrome, obsessive compulsive disorder | Topical metronidazole, topical steroids, gabapentin, topiramate, botulinum toxin type A, laser therapy, thoracic sympathectomy, clonidine, propranolol | Topical glycopyrrolate, 3%; prazosin, memantine NMDA-receptor antagonist |
10/F/53/5 | Oral lichen planus, headaches | Topical sulfa | Amoxicillin |
11/F/32/12 | Headaches | Topical metronidazole, topical steroids, gabapentin, pregabalin | Topical capsaicin, duloxetine |
12/F/60/2 | Complex regional pain syndrome, Raynaud phenomenon, depression, esophageal dysmotility, positive ANA without other known autoimmune disease | Topical metronidazole, topical steroids, topical doxepin | Gabapentin, hydroxychloroquine |
13/F/37/8 | Anxiety, depression, headaches, Raynaud phenomenon | Topical sulfasalazine, topical metronidazole, azelaic acid, doxycycline, gabapentin, intense pulsed light, topical amitriptyline, topical ketamine | Titanium dioxide, hydroxychloroquine, amitriptyline, propranolol |
14/F/22/9 | Systemic lupus erythematosus, Raynaud phenomenon | Topical metronidazole, oral tetracyclines, gabapentin, pregabalin, β-blockers, vascular laser therapy, topical doxepin, topical ketamine | Hydroxychloroquine, memantine |
Abbreviations: ANA, antinuclear antibody; NA, not applicable; NMDA, N-methyl-D-aspartic acid.